- WAKIX Q3 net revenue up 12% YoY to $269M with 400 net patient adds
- GAAP net income at $48.2M (diluted EPS of $0.81 vs $0.87 prior year)
- Reaffirmed FY net revenue guidance of $1.0B to $1.04B
Bullish AI Sentiment (+3.0 / 10)
Signal #129410 · SEC 8-K
$HRMY SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $HRMY filing catalyst
Why did $HRMY trigger an AI stock catalyst alert?
$HRMY triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Harmony Biosciences Reports Q3 Revenue of $269M, Reaffirms FY Guidance of $1.0B-$1.04B. Key points: - WAKIX Q3 net revenue up 12% YoY to $269M with 400 net patient adds - GAAP net income at $48.2M (diluted EPS of $0.81 vs $0.87 prior year) - Reaffirmed FY net revenue guidance of $1.0B to $1.04B
How did $HRMY stock react after the SEC filing?
After the SEC 8-K for $HRMY, observed market reaction: T0 price $37.02. Past moves do not guarantee future results.
Where can I get real-time $HRMY SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $HRMY via Telegram and the VIP Web Terminal from €10/month.